Increased tissue kallikrein levels in type 2 diabetes

Diabetologia

Volumn 53, Issue 4, 2010, Pages 779-785

  Campbell, D J ^a,b   Kladis, A ^a   Zhang, Y ^b   Jenkins, A J ^b   Prior, D L ^a,b,c   Yii, M ^c   Kenny, J F ^c   Black, M J ^d   Kelly, D J ^b  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Monash University ^*  (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Aldosterone; Angiotensin; Bradykinin; Immunohistochemistry; Kallidin; Kallikrein; Kallistatin; Kininogen; Statin; Type 2 diabetes

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRADYKININ; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; KALLIDIN; LOW MOLECULAR WEIGHT KININOGEN; MESSENGER RNA; NITRIC ACID DERIVATIVE; STATIN; TISSUE KALLIKREIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CORONARY ARTERY BYPASS GRAFT; DIABETIC PATIENT; ENDOTHELIUM; FEMALE; HEART ATRIUM; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; KALLIKREIN KININ SYSTEM; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOTONIC AGENTS; CORONARY ARTERY BYPASS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; ENDOTHELIUM, VASCULAR; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNOHISTOCHEMISTRY; RNA, MESSENGER; TISSUE KALLIKREINS;

EID: 77949267083     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-009-1645-8     Document Type: Article

References (28)

1. DJ Campbell 2001 The kallikrein-kinin system in humans Clin Exp Pharmacol Physiol 28 1060 1065 10.1046/j.1440-1681.2001.03564.x 1:CAS:528:DC%2BD38XptVWh 11903316 (Pubitemid 34053524)
2. F Spillmann S van Linthout HP Schultheiss C Tschope 2006 Cardioprotective mechanisms of the kallikrein-kinin system in diabetic cardiopathy Curr Opin Nephrol Hypertens 15 22 29 10.1097/01.mnh.0000199009.56799.2b 1:CAS:528:DC%2BD28XhsFSmtbo%3D 16340662
3. A Pizard C Richer N Bouby, et al. 2008 Genetic deficiency in tissue kallikrein activity in mouse and man: effect on arteries, heart and kidney Biol Chem 389 701 706 10.1515/BC.2008.081 1:CAS:528:DC%2BD1cXos1ehu7c%3D 18627303 (Pubitemid 352009414)
4. M Marre X Jeunemaitre Y Gallois, et al. 1997 Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes J Clin Invest 99 1585 1595 10.1172/JCI119321 1:CAS:528:DyaK2sXitlantLY%3D 9120002
5. W Huang Y Gallois N Bouby, et al. 2001 Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse Proc Natl Acad Sci USA 98 13330 13334 10.1073/pnas.231476798 1:CAS:528: DC%2BD3MXosFygtLg%3D 11687636 (Pubitemid 33051362)
6. CJ Zeitz DJ Campbell JD Horowitz 2003 Myocardial uptake and biochemical and hemodynamic effects of ACE inhibitors in humans Hypertension 41 482 487 10.1161/01.HYP.0000054976.67487.08 1:CAS:528:DC%2BD3sXhsV2lu7w%3D 12623947 (Pubitemid 36314620)
7. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators 2000 Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE Study and MICRO-HOPE Substudy. Heart Outcomes Prevention Evaluation Study Investigators Lancet 355 253 259 10.1016/S0140-6736(99)12323-7 (Pubitemid 30068516)
8. EJ Lewis LG Hunsicker WR Clarke, et al. 2001 Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes N Engl J Med 345 851 860 10.1056/NEJMoa011303 1:CAS:528:DC%2BD3MXntlelsLg%3D 11565517 (Pubitemid 34940824)
9. DJ Campbell H Krum MD Esler 2005 Losartan increases bradykinin levels in hypertensive humans Circulation 111 315 320 10.1161/01.CIR.0000153269.07762.3B 1:CAS:528:DC%2BD2MXmtFertQ%3D%3D 15655136 (Pubitemid 40165338)
10. DJ Campbell DJ Kelly JL Wilkinson-Berka ME Cooper SL Skinner 1999 Increased bradykinin and "normal" angiotensin peptide levels in diabetic Sprague-Dawley and transgenic (mRen-2)27 rats Kidney Int 56 211 221 10.1046/j.1523-1755.1999.00519.x 1:CAS:528:DyaK1MXksVyjsr4%3D 10411695 (Pubitemid 29300537)
11. S John M Schlaich M Langenfeld, et al. 1998 Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study Circulation 98 211 216 1:CAS:528:DyaK1cXltVKltLs%3D 9697820
12. SH Wilson RD Simari PJ Best, et al. 2001 Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid lowering Arterioscler Thromb Vasc Biol 21 122 128 10.1161/hq1101.097805 1:CAS:528:DC%2BD3MXnvFKlsg%3D%3D 11145943
13. AS Levey JP Bosch JB Lewis T Greene N Rogers D Roth 1999 A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 461 470 1:CAS:528:DyaK1MXitFChs7k%3D 10075613
14. TM Wallace JC Levy DR Matthews 2004 Use and abuse of HOMA modeling Diabetes Care 27 1487 1495 10.2337/diacare.27.6.1487 15161807 (Pubitemid 38680001)
15. AS Januszewski MC Thomas SJ Chung, et al. 2005 Plasma low-molecular weight fluorescence in type 1 diabetes mellitus Ann NY Acad Sci 1043 655 661 10.1196/annals.1333.074 1:CAS:528:DC%2BD2MXpvVKqtbc%3D 16037289 (Pubitemid 41123956)
16. A-M Duncan A Kladis GL Jennings AM Dart M Esler DJ Campbell 2000 Kinins in humans Am J Physiol Regul Integr Comp Physiol 278 R897 R904 1:CAS:528:DC%2BD3cXislSksLs%3D 10749777
17. AM Rothschild G Boden RW Colman 1996 Kininogen changes in human plasma following a test meal or insulin administration Am J Physiol Heart Circ Physiol 270 H1071 H1077 1:CAS:528:DyaK28XitVeksrg%3D
18. D Veloso LD Silver S Hahn RW Colman 1987 A monoclonal anti-human plasma prekallikrein antibody that inhibits activation of prekallikrein by factor XIIa on a surface Blood 70 1053 1062 1:CAS:528:DyaL1cXntFWktw%3D%3D 2443201
19. D Veloso RW Colman 1991 Western blot analyses of prekallikrein and its activation products in human plasma Thromb Haemost 65 382 388 1:CAS:528:DyaK3MXlsFemsL8%3D 1711719
20. JL Chao A Schmaier LM Chen ZR Yang L Chao 1996 Kallistatin, a novel human tissue kallikrein inhibitor: levels in body fluids, blood cells, and tissues in health and disease J Lab Clin Med 127 612 620 10.1016/S0022-2143(96)90152-3 1:CAS:528:DyaK28XktlCgu7Y%3D 8648266 (Pubitemid 26310340)
21. M Kemme D Podlich DM Raidoo C Snyman S Naidoo KD Bhoola 1999 Identification of immunoreactive tissue prokallikrein on the surface membrane of human neutrophils Biol Chem 380 1321 1328 10.1515/BC.1999.168 1:CAS:528:DyaK1MXotFKjs7k%3D 10614825
22. AS Barth S Merk E Arnoldi, et al. 2005 Reprogramming of the human atrial transcriptome in permanent atrial fibrillation: expression of a ventricular-like genomic signature Circ Res 96 1022 1029 10.1161/01.RES.0000165480.82737.33 1:CAS:528:DC%2BD2MXjvFynsbc%3D 15817885 (Pubitemid 40712803)
23. W Xiong L-M Chen C Woodley-Miller JA Simson J Chao 1990 Identification, purification, and localization of tissue kallikrein in rat heart Biochem J 267 639 646 1:CAS:528:DyaK3cXitFWmsro%3D 2140256
24. SB Williams JA Cusco MA Roddy MT Johnstone MA Creager 1996 Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus J Am Coll Cardiol 27 567 574 10.1016/0735-1097(95)00522-6 1:STN:280:DyaK283gsVyjtA%3D%3D 8606266 (Pubitemid 26081917)
25. H Ide S Fujiya Y Aanuma Y Agishi 1990 Effects of simvastatin, an HMG-CoA reductase inhibitor, on plasma lipids and steroid hormones Clin Ther 12 410 420 1:STN:280:DyaK3M%2FpvVKhuw%3D%3D 2268863
26. DJ Campbell 1982 Effect of rat plasma lipoproteins on aldosterone production by rat zona glomerulosa cells in vitro J Steroid Biochem 17 709 711 10.1016/0022-4731(82)90576-3 1:CAS:528:DyaL3sXktFKktL4%3D 7176662 (Pubitemid 13203498)
27. KP Ohman 1997 Circulating kallikreins in normotensive and hypertensive humans: effects of mineralocorticoid administration Blood Press 6 214 222 10.3109/08037059709062072 1:CAS:528:DyaK2sXmtVGntL8%3D 9296308
28. AA Jaffa DH Miller GS Bailey J Chao HS Margolius RK Mayfield 1987 Abnormal regulation of renal kallikrein in experimental diabetes: effects of insulin on prokallikrein synthesis and activation J Clin Invest 80 1651 1659 10.1172/JCI113254 1:CAS:528:DyaL1cXjt1ekug%3D%3D 3316279